Home Industries Your guide to the Trump drug price plan: who it affects and how
MarketWatch ^ | May 16, 2018 | Emma Court
Posted on 5/17/2018, 7:18:18 AM by gattaca
President Donald Trump’s new plan, “American Patients First,” is supposed to make U.S. drug prices cheaper. But the proposal isn’t expected to hurt drugmakers, middlemen or any other part of the U.S. drug supply chain, at least for now. For some players, there could be long-term concerns, including for pharmacy-benefit managers and other drug system middlemen. Many, though, had their shares surge after Trump’s speech on Friday, where he introduced the plan.
(Excerpt) Read more at marketwatch.com …